[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368182-105":59,"doc-detail-368182-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","enhancing-radiation-therapy-response-in-prostate-cancer-through-metabolic-modulation-by-mito-lonidamine-a-1h-and-31p-magnetic-resonance-spectroscopy-study","Enhancing Radiation Therapy Response in Prostate Cancer Through Metabolic Modulation by Mito-Lonidamine - A 1H and 31P Magnetic Resonance Spectroscopy Study","","Radiation therapy (RT) serves as a cornerstone treatment for prostate cancer but often causes gastrointestinal and genitourinary toxicities that reduce patient quality of life, especially among those with persistent long-term complications. This study evaluates mito-lonidamine (Mito-LND) as a radiosensitizer targeting mitochondrial electron transport chain complexes I and II. Comprehensive in vitro and in vivo experiments in hormone-sensitive and hormone-refractory prostate cancer models show selective suppression of lactate production, intracellular acidification, and reduced bioenergetics and oxygen consumption. Using Seahorse analysis and 1H/31P magnetic resonance spectroscopy, results indicate tumor microenvironment remodeling via acidification, metabolic de-energization, and improved oxygenation, thereby sensitizing tumors to RT. Findings support Mito-LND as a therapeutic adjunct to enhance outcomes and reduce radiation-associated toxicities in early-stage disease.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/enhancing-radiation-therapy-response-in-prostate-cancer-through-metabolic-modulation-by-mito-lonidamine-a-1h-and-31p-magnetic-resonance-spectroscopy-study/368182/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/enhancing-radiation-therapy-response-in-prostate-cancer-through-metabolic-modulation-by-mito-lonidamine-a-1h-and-31p-magnetic-resonance-spectroscopy-study/368182.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does radiation therapy for prostate cancer cause significant patient toxicity?","Question",{"text":112,"@type":113},"Radiation therapy can frequently induce gastrointestinal and genitourinary toxicities that diminish quality of life, with some patients experiencing persistent long-term complications.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does mito-lonidamine (Mito-LND) relate to improving radiation response?",{"text":117,"@type":113},"Mito-LND targets mitochondrial electron transport chain complexes I and II and is proposed to act as a radiosensitizer by modifying tumor metabolism and microenvironment conditions.",{"name":119,"@type":110,"acceptedAnswer":120},"What key metabolic and bioenergetic changes were observed after Mito-LND treatment?",{"text":121,"@type":113},"Mito-LND selectively suppressed lactate production, decreased intracellular pH, and reduced tumor-cell bioenergetics and oxygen consumption, consistent with metabolic de-energization and tumor microenvironment remodeling.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368182,1790806128,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nEnhancing Radiation Therapy Response in Prostate Cancer Through Metabolic Modulation by Mito-Lonidamine: A 1 H and 31 P Magnetic Resonance Spectroscopy Study  \nStepan Orlovskiy 1,†, Pradeep Kumar Gupta 1,†, Fernando Arias-Mendoza 1,2, Dinesh Kumar Singh 1, Skyler Nova 1, David S. Nelson 1, Vivek Narayan 3, Cameron J. Koch 4, Micael Hardy 5, Ming You 6, Balaraman Kalyanaraman 7 and Kavindra Nath 1, *  \nAcademic Editors: Giovanni  \nLuca Gravina and Emily Capone Received: 28 November 2024  \nRevised: 13 December 2024  \nAccepted: 16 December 2024  \nPublished: 9 January 2025  \nCitation: Orlovskiy, S.; Gupta, P.K.; Arias-Mendoza, F.; Singh, D.K.; Nova, S.; Nelson, D.S.; Narayan, V.; Koch, C.J.; Hardy, M.; You, M.; et al. Enhancing Radiation Therapy Response in Prostate Cancer Through Metabolic Modulation by  \nMito-Lonidamine: A 1H and 31P Magnetic Resonance Spectroscopy Study. Int. J. Mol. Sci. 2025, 26, 509 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms26020509  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA;  \n[stepano@sas.upenn.edu](stepano@sas.upenn.edu) (S.O.); [pradeep.gupta@pennmedicine.upenn.edu](pradeep.gupta@pennmedicine.upenn.edu) (P.K.G.);  \n[fernando.arias-mendoza@pennmedicine.upenn.edu](fernando.arias-mendoza@pennmedicine.upenn.edu) (F.A.-M.);  \n[dinesh.singh@pennmedicine.upenn.edu](dinesh.singh@pennmedicine.upenn.edu) (D.K.S.); [snova@sas.upenn.edu](snova@sas.upenn.edu) (S.N.);  \n[dsnelson@pennmedicine.upenn.edu](dsnelson@pennmedicine.upenn.edu) (D.S.N.)  \n2 Advanced Imaging Research Inc., Cleveland, OH 44114, USA  \n3 Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; [vnarayan@pennmedicine.upenn.edu](vnarayan@pennmedicine.upenn.edu)  \n4 Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA; [kochc@pennmedicine.upenn.edu](kochc@pennmedicine.upenn.edu)  \n5 Département de Chimie, Aix-Marseille University, CNRS, ICR, UMR 7273, 13013 Marseille, France; [micael.hardy@univ-amu.fr](micael.hardy@univ-amu.fr)  \n6 Center for Cancer Prevention, Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, TX 77030, USA; [myou@houstonmethodist.org](myou@houstonmethodist.org)  \n7 Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA; [balarama@mcw.edu](balarama@mcw.edu)  \n* Correspondence: [kavindra.nath@pennmedicine.upenn.edu](kavindra.nath@pennmedicine.upenn.edu)[ ](kavindra.nath@pennmedicine.upenn.edu)† These authors contributed equally to this work.  \nAbstract: Radiation therapy (RT) is the cornerstone treatment for prostate cancer; however, it frequently induces gastrointestinal and genitourinary toxicities that substantially diminish the patients’ quality of life. While many individuals experience transient side effects, a subset endures persistent, long-term complications. A promising strategy to mitigate these toxicities involves enhancing tumor radiosensitivity, potentially allowing for lower radiation doses. In this context, mito-lonidamine (Mito-LND), an antineoplastic agent targeting the mitochondrial electron transport chain’s complexes I and II, emerges asa potential radiosensitizer. This study investigated Mito-LND’s capacity to augment RT efficacy and reduce adverse effects through comprehensive in vitro and in vivo assessments using hormone-sensitive and hormone-refractory prostate cancer models. Employing a Seahorse analysis and 1H/31P magnetic resonance spectroscopy (MRS), we observed that Mito-LND selectively suppressed lactate production, decreased intracellular pH, and reduced bioen","cbCainxNoPITOyGt","https://ap.wps.com/l/cbCainxNoPITOyGt","pdf",4194780,16,"English","# Introduction\n## Prostate cancer burden and diagnosis\n# Abstract and study rationale\n## RT toxicities and radiosensitization concept\n# Methods and analytical approach\n## In vitro and in vivo models\n## Seahorse analysis and 1H/31P MRS","[{\"question\":\"Why does radiation therapy for prostate cancer cause significant patient toxicity?\",\"answer\":\"Radiation therapy can frequently induce gastrointestinal and genitourinary toxicities that diminish quality of life, with some patients experiencing persistent long-term complications.\"},{\"question\":\"How does mito-lonidamine (Mito-LND) relate to improving radiation response?\",\"answer\":\"Mito-LND targets mitochondrial electron transport chain complexes I and II and is proposed to act as a radiosensitizer by modifying tumor metabolism and microenvironment conditions.\"},{\"question\":\"What key metabolic and bioenergetic changes were observed after Mito-LND treatment?\",\"answer\":\"Mito-LND selectively suppressed lactate production, decreased intracellular pH, and reduced tumor-cell bioenergetics and oxygen consumption, consistent with metabolic de-energization and tumor microenvironment remodeling.\"}]","Enhancing Radiation Therapy Response in Prostate Cancer Through Metabolic Modulation by Mito-Lonidamine - A 1H and 31P Magnetic Resonance Spectroscopy Study | PDF",1790175463,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/13919625bddb7ca1e23726da837c4404.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a328e19bd8ee40d82dfc87720e8b34b.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da722ad369403048461049160b9de131.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8acd10b4ecb1a936a1b38a10bda51d71.webp",980,1385]